Text Size

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

This study has been completed.
Sponsor:
Information provided by:
Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01123590
First received: May 12, 2010
Last updated: November 21, 2010
Last verified: November 2010
History of Changes
  Purpose

The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.


Condition
Thymoma Staging
Clinical Presentations
Associated Disorders
Laboratory Findings

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007

Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • Thymoma staging and clinical manifestations [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Associated diseases and laboratory findings Immunological data [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

PBMC


Enrollment: 50
Study Start Date: November 2009
Study Completion Date: October 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Thymoma
Patients with thymoma
Control
Normal controls

Detailed Description:

To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Criteria

Inclusion Criteria:

  • Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01123590

Locations
Thailand
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Investigators
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
  More Information

No publications provided by Chulalongkorn University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Jettanong Klaewsongkram, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01123590     History of Changes
Other Study ID Numbers: Chula-ARC 003/09
Study First Received: May 12, 2010
Last Updated: November 21, 2010
Health Authority: Thailand: Ethical Committee

Keywords provided by Chulalongkorn University:
Thymoma
Autoimmune diseases
Immunodeficiency

Additional relevant MeSH terms:
Thymoma
Neoplasms, Complex and Mixed
Neoplasms by Histologic Type
Neoplasms
 Thymus Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lymphatic Diseases

ClinicalTrials.gov processed this record on May 16, 2013